VG161

Yinan Shen1,2, Xueli Bai1,2, Qi Zhang1,2

  • 1Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Nature
|March 20, 2025
PubMed
概括

对于晚期肝癌而言, 这种新疗法在耐其他疗法耐药的患者中耐受性很好,